Cocomello, Lucia
Dimagli, Arnaldo
Biglino, Giovanni
Cornish, Rosie
Caputo, Massimo
Lawlor, Deborah A.
Funding for this research was provided by:
British Heart Foundation Accelerator Award (AA/18/7/34219)
University of Bristol and the UK Medical Research Council (MC_UU_00011/6)
BHF Chair in Cardiovascular Science and Clinical Epidemiology (CH/F/20/90003)
National Institute of Health Research Senior Investigator (NF-0616-10102)
British Heart Foundation Chair in Congenital Heart Disease (CH/1/32804)
Article History
Received: 16 June 2021
Accepted: 18 October 2021
First Online: 19 November 2021
Declarations
:
: Not applicable.
: Not applicable.
: All authors have completed the ICMJE uniform disclosure form at ExternalRef removed and declare the following. DAL has received funding from Wellcome, the European Research Council (ERC Advanced grant and a Horizon 2020 grant), US National Institute of Health, Diabetes UK, Roche Diagnostics and Medtronic Ltd for research unrelated to that presented here. MC has received funding from Medtronic Ltd for research unrelated to that presented. All other authors report no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.